SCHEMBL29484023

SCHEMBL29484023

NS(=O)(=O)NC[C@H]1O[C@@H](n2ccc3cncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 3/20 0.47
▸ ADK P55263 1/20 0.44
▸ NAE1 Q13564 2/20 0.44
▸ UBA1 P22314 1/20 0.44
▸ UBA3 Q8TBC4 1/20 0.44
▸ SAE1 Q9UBE0 1/20 0.44
▸ UBA2 Q9UBT2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10335631 0.81 ADA (0.57) ADK
SCHEMBL11081361 0.81 ADA (0.57) ADK
SCHEMBL11071618 0.81 ADA (0.57) ADK
SCHEMBL5508294 0.81 ADA (0.57) ADK
SCHEMBL7102573 0.74 DPP4 (0.69) —
SCHEMBL18572234 0.72 PRMT5 (0.75) —
SCHEMBL25956956 0.72 PRMT5 (0.75) —
SCHEMBL18297537 0.72 CA2 (0.66) CA2ADKNAE1UBA1UBA3
SCHEMBL12652510 0.71 DNPH1 (0.64) —
SCHEMBL18572413 0.71 METTL3 (0.65) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022056252-A1 COMPOSITIONS AND METHODS FOR TREATING HYPERGLYCEMIA IN TYPE-2 DIABETES THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2022-03-17 — — WO disclosed
Send feedback